Evidence map›Paper›PMID 40875527›Full record

ArticleThe Journal of clinical investigation2025

Reduced heparan sulfate levels in cerebrospinal fluid reflect brain neuron correction in Sanfilippo B mice.

Steven Q Le, Alexander Sorensen, Soila Sukupolvi, Gianna Jewhurst, Grant Austin, Balraj Doray, Jonathan D Cooper, Patricia I Dickson

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Steven Q Le
Alexander Sorensen
Soila Sukupolvi
Gianna Jewhurst
Grant Austin
Balraj Doray
Jonathan D Cooper
Patricia I Dickson

Funding

Systems-Level Approach to Neuronopathic Lysosomal Storage DisordersRM1NS132962 · NINDS · WASHINGTON UNIVERSITY · PI JONATHAN D COOPER, PATRICIA I DICKSON · 2023 to 2026
$6.3M
Infectious Disease/Immunology Stimulating Access to Research in Residency (ID/IMM StARR) Program at Washington UniversityR38AI174266 · NIAID · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 2023 to 2025
$1.5M
NIAID NIH HHS R38 AI174266NINDS NIH HHS RM1 NS132962
6 · The paper itself

Abstract

A biomarker in spinal fluid reflects brain disease in a rare genetic disorder, with implications for how we diagnose and monitor the disease.

Indexed as

BrainHeparan SulfateMucopolysaccharidosis IIINeuronsAnimalsBiomarkersDisease Models, AnimalHumansMiceBiomarkersHeparan SulfateBiomarkersGeneticsLysosomesNeurological disordersNeuroscience

Identifiers

PMID40875527
PMCPMC12618054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.